UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes

The New England journal of medicine, 2016-12, Vol.375 (22), p.2144-2153

2016

Link zum Volltext

Verfügbarkeit prüfen

Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis

Pharmacological reviews, 2006-09, Vol.58 (3), p.342

2006

Link zum Volltext

Verfügbarkeit prüfen

Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities

Arteriosclerosis, thrombosis, and vascular biology, 2013-12, Vol.33 (12), p.2715

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of Two Intensive Statin Regimens on Progression of Coronary Disease

The New England journal of medicine, 2011-12, Vol.365 (22), p.2078-2087

2011

Link zum Volltext

Verfügbarkeit prüfen

Cholesterol crystals and atherosclerotic plaque instability: Therapeutic potential of Eicosapentaenoic acid

Pharmacology & therapeutics (Oxford), 2022-12, Vol.240, p.108237-108237, Article 108237

2022

Link zum Volltext

Verfügbarkeit prüfen

Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics

European heart journal, 2020-06, Vol.41 (24), p.2304-2312

2020

Link zum Volltext

Verfügbarkeit prüfen

Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel

The lancet. Diabetes & endocrinology, 2016-10, Vol.4 (10), p.850-861

2016

Link zum Volltext

Verfügbarkeit prüfen

LDL subclass lipidomics in atherogenic dyslipidemia: effect of statin therapy on bioactive lipids and dense LDL[S]

Journal of lipid research, 2020-06, Vol.61 (6), p.911-932

2020

Link zum Volltext

Verfügbarkeit prüfen

Concerns regarding NMR lipoprotein analyses performed on the Nightingale heath platform – Focus on LDL subclasses

Journal of clinical lipidology, 2022-05, Vol.16 (3), p.250-252

2022

Link zum Volltext

Verfügbarkeit prüfen

A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma

Journal of lipid research, 2008-10, Vol.49 (10), p.2230-2239

2008

Link zum Volltext

Verfügbarkeit prüfen

Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate

Journal of lipid research, 2018-01, Vol.59 (1), p.25-34

2018

Link zum Volltext

Verfügbarkeit prüfen

High-density lipoproteins: A consensus statement from the National Lipid Association

Journal of clinical lipidology, 2013-09, Vol.7 (5), p.484-525

2013

Link zum Volltext

Verfügbarkeit prüfen

Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A

Biochimica et biophysica acta, 2015-09, Vol.1851 (9), p.1254-1261

2015

Link zum Volltext

Verfügbarkeit prüfen

Pitavastatin treatment remodels the HDL subclass lipidome and proteome in hypertriglyceridemia

Journal of lipid research, 2024-02, Vol.65 (2), p.100494-100494, Article 100494

2024

Link zum Volltext

Verfügbarkeit prüfen

Biological activities of HDL subpopulations and their relevance to cardiovascular disease

Trends in molecular medicine, 2011-10, Vol.17 (10), p.594-603

2011

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein-apheresis in familial hypercholesterolemia: Long-term patient compliance in a French cohort

Atherosclerosis, 2018-10, Vol.277, p.66-71

2018

Link zum Volltext

Verfügbarkeit prüfen

HDL functionality in type 1 and type 2 diabetes: new insights

Current opinion in endocrinology, diabetes, and obesity, 2022-04, Vol.29 (2), p.112

Chapman, M John

2022

Link zum Volltext

Verfügbarkeit prüfen

Why is HDL functionally deficient in type 2 diabetes?

Current diabetes reports, 2008-02, Vol.8 (1), p.51-59

2008

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap

European heart journal supplements, 2020-10, Vol.22 (Supplement_J), p.J21-J33

2020

Link zum Volltext

Verfügbarkeit prüfen

Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: Relevance of inflammation

Atherosclerosis, 2014-12, Vol.237 (2), p.652-660

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.544

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.132)
Mit Volltextzugriff
(2.193)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.590)
Life Sciences & Biomedicine
(1.349)
Humans
(1.104)
Male
(627)
Female
(604)
Biological And Medical Sciences
(512)
Medical Sciences
(389)
Middle Aged
(375)
Adult
(362)
Animals
(321)
Aged
(263)
Cardiovascular System & Cardiology
(227)
Biochemistry & Molecular Biology
(166)
Fundamental And Applied Biological Sciences. Psychology
(166)
Physical Sciences
(154)
Cardiac & Cardiovascular Systems
(153)
Risk Factors
(141)
Peripheral Vascular Disease
(136)
Life Sciences
(127)
Adolescent
(125)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis

Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities

Effect of Two Intensive Statin Regimens on Progression of Coronary Disease

Cholesterol crystals and atherosclerotic plaque instability: Therapeutic potential of Eicosapentaenoic acid

ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics

Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel

LDL subclass lipidomics in atherogenic dyslipidemia: effect of statin therapy on bioactive lipids and dense LDL[S]

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with Dyslipidemia

Concerns regarding NMR lipoprotein analyses performed on the Nightingale heath platform – Focus on LDL subclasses

A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma

Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate

High-density lipoproteins: A consensus statement from the National Lipid Association

Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A

Pitavastatin treatment remodels the HDL subclass lipidome and proteome in hypertriglyceridemia

Biological activities of HDL subpopulations and their relevance to cardiovascular disease

Lipoprotein-apheresis in familial hypercholesterolemia: Long-term patient compliance in a French cohort

HDL functionality in type 1 and type 2 diabetes: new insights

Why is HDL functionally deficient in type 2 diabetes?

Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap

Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: Relevance of inflammation

Suchergebnisse filtern